Heartbeam Inc (BEAT)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Heartbeam Inc Stock (BEAT) Company Profile

Heartbeam Inc

Healthcare (1233)

408-899-4443

2118 WALSH AVE., SUITE 210, SANTA CLARA

Prossima data di guadagno

Ultimi documenti SEC

BEAT's Discussions on Twitter

Confronta BEAT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BEAT Heartbeam Inc	2.135	56.80M	0	-14.47M	-12.19M	-1.24
VEEV Veeva Systems Inc	216.21	35.28B	2.66B	665.91M	1.08B	4.05
SOLV Solventum Corp	68.45	11.91B	8.26B	66.00M	1.17B	0.3682
DOCS Doximity Inc	52.74	9.75B	516.85M	174.11M	217.38M	0.87
HQY Healthequity Inc	100.55	8.68B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	37.07	6.45B	906.14M	-52.62M	89.62M	-0.3621

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-09-11	Iniziato	Needham	Buy
2020-09-02	Iniziato	Robert W. Baird	Neutral
2020-01-08	Iniziato	SunTrust	Buy
2019-08-02	Downgrade	Raymond James	Outperform → Mkt Perform
2019-04-26	Reiterato	Dougherty & Company	Buy
2018-07-26	Reiterato	Lake Street	Buy
2018-04-26	Reiterato	The Benchmark Company	Buy
2018-02-23	Reiterato	Dougherty & Company	Buy
2017-11-08	Reiterato	Dougherty & Company	Buy
2017-10-26	Iniziato	Raymond James	Outperform
2017-10-24	Iniziato	SunTrust	Buy
2017-08-09	Reiterato	Dougherty & Company	Buy
2017-07-19	Reiterato	The Benchmark Company	Buy
2017-04-11	Reiterato	Dougherty & Company	Buy
2016-12-02	Iniziato	Dougherty & Company	Buy
2016-09-13	Iniziato	Sidoti	Buy
2016-08-03	Reiterato	The Benchmark Company	Buy
2015-07-28	Reiterato	Dougherty & Company	Buy
2013-10-24	Iniziato	The Benchmark Company	Buy
2013-08-21	Iniziato	Dougherty & Company	Buy

Mostra tutto

Heartbeam Inc Borsa (BEAT) Ultime notizie

Heartbeam Inc Azioni (BEAT) Dati Finanziari

Heartbeam Inc (BEAT)

Heartbeam Inc Stock (BEAT) Company Profile

Confronta BEAT con altri titoli

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Heartbeam Inc Borsa (BEAT) Ultime notizie

JP Morgan Chase & Company (JPM-N) QuotePress Release - The Globe and Mail

HeartBeam (NASDAQ: BEAT) To Present At JP Morgan 2025 Annual Healthcare Conference - Barchart

Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail

HeartBeam to Showcase FDA-Cleared Revolutionary Heart Monitor at JP Morgan Healthcare Conference - StockTitan

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference - Business Wire

HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance - Yahoo! Voices

FDA clearance adds glow to Heartbeam prospects - BioWorld Online

HeartBeam Wins FDA Nod for Home High-Fidelity Heart Monitor - MPO-mag

HeartBeam announces FDA clearance for high-fidelity ECG system - TipRanks

Heartbeam stock soars to 52-week high, hits $3.48 - Investing.com

FDA clears HeartBeam's novel ECG system for arrhythmia - Investing.com India

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology - Business Wire

HeartBeam And 2 Other US Penny Stocks With Promising Potential - Simply Wall St

The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times

HeartBeam rises on positive data from two studies on its vector-based technology - MSN

HeartBeam ECG technology shows promise in clinical studies By Investing.com - Investing.com Australia

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference - BioSpace

HeartBeam Touts Data from Study of Vector-Based Tech - MPO-mag

HeartBeam ECG technology shows promise in clinical studies - Investing.com India

HeartBeam announces positive data from two studies at AHA - TipRanks

HeartBeam, Inc. (NASDAQ:BEATW) Short Interest Update - Defense World

HeartBeam, Inc. (NASDAQ:BEAT) Q3 2024 Earnings Call Transcript - Insider Monkey

HeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA Submissions - Barchart

HeartBeam reports net loss of USD 5M in Q3 2024 - Medical Buyer

HeartBeam, Inc. Advances Cardiac Monitoring Solutions - TipRanks

HeartBeam Q3 Loss Widens to $5M as FDA Review Advances for Cardiac Tech | BEAT Stock News - StockTitan

Spotlight On US Penny Stocks In October 2024 - Simply Wall St

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time - Business Wire

Tripp Investments Alters Stake in Betmakers - MSN

Severfield PLC Executes Share Buy-Back on LSE - MSN

HeartBeam, Inc. (BEAT): A Bull Case Theory - Insider Monkey

HeartBeam (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care - Barchart

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards - Business Wire

HeartBeam Appoints Robert Eno as New CEO - TipRanks

Upstart Holdings, Inc. (UPST) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN

Diamondback Energy (FANG) Rises Yet Lags Behind Market: Some Facts Worth Knowing - MSN

Lifesaving Portable, AI Augmented Cardiac Monitoring - openPR

HeartBeam names Robert Eno as new CEO for growth phase - Investing.com

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization - Business Wire

HeartBeam Appoints Robert Eno as Chief Exec - MPO-mag

Dr. Lance Myers Joins HeartBeam As Chief AI Scientist - MPO-mag

Dr. Lance Myers Joins HeartBeam as Chief AI Scientist - MPO-mag

Short Interest in HeartBeam, Inc. (NASDAQ:BEATW) Decreases By 17.6% - Defense World

HeartBeam appoints AI expert Lance Myers as Chief Scientist - Investing.com

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist - Business Wire

Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation - Simply Wall St

Is HeartBeam (NASDAQ:BEAT) In A Good Position To Invest In Growth? - Yahoo Finance

Timothy Cruickshank named HeartBeam CFO - Medical Buyer

Heartbeam stock retains Speculative Buy rating despite near-term risks - Investing.com India

HeartBeam Names Timothy Cruickshank As CFO - MPO-mag

Heartbeam Inc Azioni (BEAT) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a BEAT